AIIC
BLCM

AJU IB Investment Company’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

AJU IB Investment Company’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,651
Closed -$75K – 13
2021
Q3 		$75K Hold
25,651
– – 0.05% 11
2021
Q2 		$85K Hold
25,651
– – 0.05% 11
2021
Q1 		$96K Hold
25,651
– – 0.04% 11
2020
Q4 		$91K Buy
+25,651
New +$108K 0.03% 11

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AJU IB Investment Company's BLCM Position: Q4 2021 in Review

AJU IB Investment Company sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2021, closing a stake of 25,651 shares — an estimated $75K sold.

AJU IB Investment Company first reported a position in BLCM in Q4 2020 and held it in 4 quarters. The position peaked at $96K in Q1 2021. 24 funds tracked by Wall St. Rank hold BLCM as of Q4 2021.

  • AJU IB Investment Company reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • AJU IB Investment Company sold 25,651 Bellicum Pharmaceuticals, Inc. shares in Q4 2021, an estimated $75K.
  • AJU IB Investment Company first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
  • AJU IB Investment Company's Bellicum Pharmaceuticals, Inc. position peaked at $96K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2021.

Based on AJU IB Investment Company's 13F filing for Q4 2021, filed 9 Feb 2022.